In a small cell therapy trial, 10 out of 12 participants with type 1 diabetes no longer required supplemental insulin one year after treatment. This represents a promising advancement in diabetes management.

Trial Results

The therapy involved implanting lab-grown cells that produce insulin, showing long-term efficacy in most patients.

Future Prospects

Larger trials are planned to confirm safety and effectiveness.

Source: Science News